Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-21 Sale |
2021-09-23 4:30 pm |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
300 | $12.31 | $3,692 | 3,500 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-23 4:29 pm |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
250 | $12.3 | $3,074 | 3,090 (Direct) |
View |
| 2021-06-21 Sale |
2021-06-22 5:06 pm |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
300 | $15.2 | $4,559 | 3,800 (Direct) |
View |
| 2021-06-21 Sale |
2021-06-22 5:05 pm |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
250 | $15.2 | $3,801 | 3,340 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 6:03 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,529 | $17.66 | $27,009 | 3,163 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-16 8:59 pm |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
300 | $17.51 | $5,254 | 4,100 (Direct) |
View |
| 2021-04-06 Sale |
2021-04-07 5:04 pm |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
250 | $17.22 | $4,305 | 3,590 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-15 4:30 pm |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
827 | $18.09 | $14,960 | 18,750 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-08 6:07 pm |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
3,571 | $19.66 | $70,219 | 0 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-23 4:23 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $20 | $200,000 | 48,416 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-01 6:48 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development |
1,158 | $13.97 | $16,176 | 1,158 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-30 Other |
2021-07-15 4:52 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,530 | $13.9 | 20,944 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:52 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
433 | $13.48 | 20,944 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:52 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,250 | $0 | 20,944 (Direct) |
View |
| 2021-04-30 Other |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,529 | $13.9 | 148,328 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $13.48 | 148,328 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,645 | $0 | 148,328 (Direct) |
View |
| 2021-04-30 Other |
2021-07-15 4:49 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
971 | $13.9 | 39,423 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:49 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
433 | $13.48 | 39,423 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:49 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
1,250 | $0 | 39,423 (Direct) |
View |
| 2021-04-30 Other |
2021-07-15 4:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
1,530 | $13.9 | 22,543 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
191 | $13.48 | 22,543 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
552 | $0 | 22,543 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:47 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $13.48 | 18,701 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:47 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 18,701 (Direct) |
View |
| 2021-04-30 Other |
2021-05-04 6:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,529 | $13.9 | 3,163 (Direct) |
View |
| 2021-04-13 Tax Withholding |
2021-04-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
433 | $16.66 | 18,317 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,250 | $0 | 18,317 (Direct) |
View |
| 2021-04-13 Tax Withholding |
2021-04-15 4:53 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
433 | $16.66 | 37,914 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 4:53 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
1,250 | $0 | 37,914 (Direct) |
View |
| 2021-04-13 Tax Withholding |
2021-04-15 4:52 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
191 | $16.66 | 19,674 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 4:52 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
552 | $0 | 19,674 (Direct) |
View |
| 2021-04-13 Tax Withholding |
2021-04-15 4:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $16.66 | 19,134 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 4:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 19,134 (Direct) |
View |
Ownership |
2021-02-16 4:18 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | TANG KEVIN C Former Director Director |
0 | $0 | 3,445 (Indirect) |
View |
| 2020-01-06 Ownership |
2021-02-16 4:18 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | TANG KEVIN C Former Director Director |
2,120,299 | $0 | 3,445 (Indirect) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:30 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
1,250 | $0 | 18,750 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:30 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
423 | $18.16 | 18,750 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:29 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,646 | $0 | 146,596 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:29 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $18.16 | 146,596 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
1,250 | $0 | 38,347 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:27 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
433 | $18.16 | 38,347 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
552 | $0 | 19,865 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
227 | $18.16 | 19,865 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 19,567 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $18.16 | 19,567 (Direct) |
View |
| 2020-10-30 Other |
2020-12-23 4:24 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
637 | $11.65 | 19,417 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $13 | 48,416 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:23 pm |
N/A 2026-12-21 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $0 | 48,416 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:21 pm |
N/A 2030-12-21 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
21,000 | $0 | 22,400 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:21 pm |
N/A 2030-12-21 |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
21,000 | $0 | 21,840 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:20 pm |
N/A 2030-12-21 |
HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director |
21,000 | $0 | 21,000 (Direct) |
View |
Ownership |
2020-10-20 5:16 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer |
0 | $0 | 775,738 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:35 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
111,833 | $0 | 111,833 (Direct) |
View |
Ownership |
2020-10-15 4:28 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
0 | $0 | 230,236 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:25 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
140,000 | $0 | 140,000 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:24 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO |
190,000 | $0 | 190,000 (Direct) |
View |
| 2020-04-30 Other |
2020-10-15 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,158 | $12.12 | 498,717 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:23 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
408,333 | $0 | 498,717 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:21 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
437 | $0 | 437 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:20 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | DAVIS STEPHEN Director |
765 | $0 | 765 (Direct) |
View |
| 2020-04-30 Other |
2020-05-01 6:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development |
1,158 | $12.12 | 1,158 (Direct) |
View |